Authors
Latest:
The Effects of Multidose Ketamine Treatment on Cognitive Performance Over Time in Patients With TRDExperts present the results of a retrospective analysis of patients who received IV ketamine for TRD over a timeframe of up to 2 years.
Latest:
You Say Pain. I Say Addiction. Let’s Call the Whole Thing OffThis CME will inform clinicians with unique and much-needed skill sets in diagnosing substance use disorders and managing co-occurring chronic pain.
Latest:
Let’s Ask the Right Questions About Medical Aid in DyingSome patients are intractably and maybe even irredeemably ill. What should be done for them?
Latest:
Closing the Confidence Gap“Confidence occurs when we feel supported, when we feel connection, when we have safety, and when we have experience under our belt.”
Latest:
HIV-Associated Neurocognitive Disorder: An Updated PathophysiologyIn this CME, learn more about the pathophysiology of HIV-associated neurocognitive disorder and to review the research and various tools used to aid in the diagnosis.
Latest:
Boosting Brain Health After COVID-19: A Convergence SolutionHow can we face the current pandemic while addressing the brain health crisis?
Latest:
The Best Solution to NonadherenceMore than 50% of patients with schizophrenia are estimated to be nonadherent with their antipsychotic medication regimen. What treatment solutions are available?
Latest:
Sleep Spindles: A Comparison in Young Patients with Schizophrenia and Anti-NMDAR EncephalitisWhat can we learn from sleep in schizophrenia? New research sheds light.
Latest:
Defeating the Pandemic: The Necessity of Vaccination MandatesOur country’s mental health depends on defeating this pandemic. The key to victory? Vaccine mandates.
Latest:
Eating Disorder Exploitation in Entertainment: Helping the Artists and Their FansMany artists who have struggled with an eating disorder are generating content that is promoted by the entertainment industry, and when these conditions go unaddressed, the content has the potential to influence consumers.
Latest:
Bridging the Gap: Integrating Psychopharmacology Into Sustainable Addiction RecoveryHere’s how an integrated psychosocial and pharmacologic approach can enhance SUD treatment.
Latest:
Serotonin Reuptake Inhibitor and Bleeding Risk, Part 2: Gastrointestinal (GI) Bleeding, Malignancy, Pregnancy, and Surgical ConsiderationsIn this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.
Latest:
Barriers to Digital Therapeutics AdoptionDigital therapeutics require adoption from 3 groups: psychiatrists, payers, and patients. What needs to be done to get everyone aboard?
Latest:
Psychiatry for Primary Care: Suicide Risk Assessment and Prevention (Part 3)In the absence of definitive data, how can primary care providers help prevent suicide and provide compassionate care that promotes quality of life in their patients?
Latest:
An Introduction to Treating the Brain: An OdysseyThe history of modern psychopharmacology: a history of epic proportions.
Latest:
Psychiatrists Call for End to Cruel and Harmful Immigration PolicyThe Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.
Latest:
Mental Health as a Role in Mortality Rates in Peri- and Postpartum Black WomenBlack mothers in the US experience far worse outcomes. Here’s what clinicians need to know.
Latest:
“Oh No, My Patient is a Physician!” Hurdles When Treating Physician-PatientsCaring for physician-patients can be a challenge…
Latest:
3 Positives and Negatives to Nourish Your Mental HealthMental health support is only as good as the foundation upon which it is built.
Latest:
Brain Capital: An Emerging Investment OpportunityBrain Capital: a fresh approach to technologies and investing.
Latest:
Exploring the New Era of Hope and Possibilities for Patients With Dementia"To be sure, we are still in the nascent stages of developing treatments. However, our armamentarium is steadily growing."
Latest:
Developing Your Skills at the Intersection of Work and PsychiatryHere’s how the Academy of Organizational and Occupational Psychiatry can help you connect with your fellow psychiatrists about complex mental health issues in the workplace.
Latest:
What to Expect When Your Patients With ADHD Are ExpectingA new study provides guidance for clinicians discussing the risks of ADHD medications with their pregnant patients.
Latest:
Curing Stubborn Depression: Educating Patients and the PublicHow can we offer options and hope for the future to patients with treatment-resistant depression?
Latest:
Why Psychiatry Training Must Include Discussions on Structural RacismThe authors explore the impact of structural racism on psychiatry trainees and the patients they care for (and what can be done about it).
Latest:
A Skeptical Look at AducanumabThe FDA approval of aducanumab has given hope to millions of patients with Alzheimer disease—but will it live up to the hype?
Latest:
Unique Collaborative Care System: Solution to the Youth Mental Health CrisisIntegrated models of care offer real time solutions by enabling primary care to identify and address behavioral health concerns through routine screening and early intervention more efficiently. Learn more here.
Latest:
Rejoyn: A Fundamental Change in How Clinicians Can Treat MDD SymptomsRejoyn was recently cleared by the FDA, making it the first prescription digital therapeutic for major depressive disorder.
Latest:
The Final “P” in Pain ManagementWith a broader and multifaceted understanding of pain, patient care can move from a focus on eradicating pain, as based on objective pain scores, to improving the patient’s quality of life, while simultaneously decreasing pain to a level that is acceptable to the individual patient.
